115563
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.6 Breast Cancer (Dove Med Press)
- 4.3 Clin Epidemiol
- 2.6 Cancer Manag Res
- 3.2 Infect Drug Resist
- 4.1 Clin Interv Aging
- 6.1 Drug Des Dev Ther
- 4.1 Int J Chronic Obstr
- 8.7 Int J Nanomed
- 2.5 Int J Women's Health
- 3.2 Neuropsych Dis Treat
- 2.4 OncoTargets Ther
- 2.6 Patient Prefer Adher
- 2.6 Ther Clin Risk Manag
- 3.1 J Pain Res
- 3.5 Diabet Metab Synd Ob
- 4.5 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 2.4 Pharmgenomics Pers Med
- 2.6 Risk Manag Healthc Policy
- 4.6 J Inflamm Res
- 2.3 Int J Gen Med
- 3.9 J Hepatocell Carcinoma
- 3.3 J Asthma Allergy
- 2.5 Clin Cosmet Investig Dermatol
- 3.0 J Multidiscip Healthc
已发表论文
腹腔感染合并肠瘘患者血清 NLR、IL-10 及 SAA 表达水平比较及不良预后危险因素研究
Authors Gao J , Guo J, Qin X, Sun Z
Received 13 September 2025
Accepted for publication 17 December 2025
Published 8 January 2026 Volume 2026:19 563393
DOI https://doi.org/10.2147/IDR.S563393
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Oliver Planz
Jun Gao,1 Jinyang Guo,1 Xiyan Qin,2 Zhide Sun1
1Emergency Department, Affiliated Hospital of Chengde Medical University, Chengde, Hebei Province, 067000, People’s Republic of China; 2Medical Materials Department, Affiliated Hospital of Chengde Medical University, Chengde, Hebei Province, 067000, People’s Republic of China
Correspondence: Zhide Sun, Emergency Department, Affiliated Hospital of Chengde Medical University, Chengde, Hebei Province, 067000, People’s Republic of China, Email 18233871160@163.com
Purpose: The purpose of this research is to investigate the expression levels of serum NLR, IL-10 and SAA, as well as risk factors for poor prognosis in patients with intestinal fistula complicated by abdominal infection.
Patients and Methods: From May 2018 to January 2025, 80 intestinal fistula patients admitted to our hospital and 36 healthy physical examinees during the same period were enrolled. Patients were divided into intestinal fistula group and intestinal fistula with abdominal infection group; the latter was further subdivided into good and poor prognosis subgroups based on hospitalization and follow-up outcomes. Serum NLR, IL-10 and SAA levels were detected before and after treatment. Logistic multiple regression was used to analyze poor prognosis-related factors, and ROC curves to evaluate the predictive value of single and combined indicators for poor prognosis in intestinal fistula patients with abdominal infection.
Results: NLR, IL-10 and SAA were significantly higher in intestinal fistula group than controls (P< 0.05), and higher in co-infection group than fistula-only group (all P< 0.05). Both groups showed post-treatment level reductions (all P< 0.05), but co-infection group still had higher levels (all P< 0.05). The three indicators were independent poor prognosis factors (all P< 0.05). Combined detection had AUC 0.970, sensitivity 0.997 and specificity 0.929.
Conclusion: Serum NLR, IL-10 and SAA are significantly elevated in intestinal fistula with abdominal infection, serving as independent prognostic factors. Their combined detection has high predictive value for poor prognosis.
Keywords: intestinal fistula, abdominal infection, NLR, IL-10, SAA, prognosis
1Emergency Department, Affiliated Hospital of Chengde Medical University, Chengde, Hebei Province, 067000, People’s Republic of China; 2Medical Materials Department, Affiliated Hospital of Chengde Medical University, Chengde, Hebei Province, 067000, People’s Republic of China
Correspondence: Zhide Sun, Emergency Department, Affiliated Hospital of Chengde Medical University, Chengde, Hebei Province, 067000, People’s Republic of China, Email 18233871160@163.com
Purpose: The purpose of this research is to investigate the expression levels of serum NLR, IL-10 and SAA, as well as risk factors for poor prognosis in patients with intestinal fistula complicated by abdominal infection.
Patients and Methods: From May 2018 to January 2025, 80 intestinal fistula patients admitted to our hospital and 36 healthy physical examinees during the same period were enrolled. Patients were divided into intestinal fistula group and intestinal fistula with abdominal infection group; the latter was further subdivided into good and poor prognosis subgroups based on hospitalization and follow-up outcomes. Serum NLR, IL-10 and SAA levels were detected before and after treatment. Logistic multiple regression was used to analyze poor prognosis-related factors, and ROC curves to evaluate the predictive value of single and combined indicators for poor prognosis in intestinal fistula patients with abdominal infection.
Results: NLR, IL-10 and SAA were significantly higher in intestinal fistula group than controls (P< 0.05), and higher in co-infection group than fistula-only group (all P< 0.05). Both groups showed post-treatment level reductions (all P< 0.05), but co-infection group still had higher levels (all P< 0.05). The three indicators were independent poor prognosis factors (all P< 0.05). Combined detection had AUC 0.970, sensitivity 0.997 and specificity 0.929.
Conclusion: Serum NLR, IL-10 and SAA are significantly elevated in intestinal fistula with abdominal infection, serving as independent prognostic factors. Their combined detection has high predictive value for poor prognosis.
Keywords: intestinal fistula, abdominal infection, NLR, IL-10, SAA, prognosis